+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Narcolepsy Treatment Market Research Report by Drug Class (CNS Stimulants, Decongestants, and Serotonin Reuptake Inhibitors), Narcolepsy Type, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 225 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968747
UP TO OFF until Dec 31st 2022
The Global Narcolepsy Treatment Market size was estimated at USD 3,017.14 million in 2021, USD 3,414.62 million in 2022, and is projected to grow at a CAGR 13.35% to reach USD 6,399.60 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Narcolepsy Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Class, the market was studied across CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors, and Vasopressors.
  • Based on Narcolepsy Type, the market was studied across Narcolepsy Type 1 and Narcolepsy Type 2.
  • Based on End User, the market was studied across Drug Stores, E-commerce, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Narcolepsy Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Narcolepsy Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Narcolepsy Treatment Market, including Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., Avadel Pharmaceuticals plc, Axsome Therapeutics, BIOPROJET, GlaxoSmithKline PLC, Graymark Healthcare Inc., Harmony Biosciences LLC, Jazz Pharmaceuticals plc, Johnson & Johnson Services Inc., Ligand Pharmaceuticals, Midas Pharma GmbH, Novartis AG, Pfizer Inc., Shire Plc, and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Narcolepsy Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Narcolepsy Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Narcolepsy Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Narcolepsy Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Narcolepsy Treatment Market?
6. What is the market share of the leading vendors in the Global Narcolepsy Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Narcolepsy Treatment Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Number of Chronic Neurological Disorder
5.1.1.2. Increasing Cases of Sleep Disorder Narcolepsy
5.1.1.3. Growing Consumer Awareness Regarding Narcolepsy Treatment
5.1.2. Restraints
5.1.2.1. Adverse Effects of the Narcolepsy Treatment
5.1.3. Opportunities
5.1.3.1. Rise in the Research Activities Related to the Narcolepsy Treatment
5.1.3.2. Growing Number of Product Launches and Favorable Reimbursement Policies
5.1.4. Challenges
5.1.4.1. Costly Diagnosis and Treatment of Narcolepsy
5.2. Cumulative Impact of COVID-19
6. Narcolepsy Treatment Market, by Drug Class
6.1. Introduction
6.2. Cns Stimulants
6.3. Decongestants
6.4. Serotonin Reuptake Inhibitors
6.5. Vasopressors
7. Narcolepsy Treatment Market, by Narcolepsy Type
7.1. Introduction
7.2. Narcolepsy Type 1
7.3. Narcolepsy Type 2
8. Narcolepsy Treatment Market, by End-user
8.1. Introduction
8.2. Drug Stores
8.3. E-Commerce
8.4. Retail Pharmacies
9. Americas Narcolepsy Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Narcolepsy Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Narcolepsy Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Addrenex Pharmaceuticals, Inc.
13.2. Arena Pharmaceuticals, Inc.
13.3. Avadel Pharmaceuticals plc
13.4. Axsome Therapeutics
13.5. Bioprojet
13.6. GlaxoSmithKline plc
13.7. Graymark Healthcare Inc.
13.8. Harmony Biosciences LLC
13.9. Jazz Pharmaceuticals plc
13.10. Johnson & Johnson Services Inc.
13.11. Ligand Pharmaceuticals
13.12. Midas Pharma GmbH
13.13. Novartis Ag
13.14. Pfizer Inc.
13.15. Shire plc
13.16. Teva Pharmaceutical Industries Ltd.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL NARCOLEPSY TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL NARCOLEPSY TREATMENT MARKET DYNAMICS
FIGURE 8. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (%)
FIGURE 9. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2021 VS 2027 (%)
FIGURE 20. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2027
FIGURE 22. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 27. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2027
FIGURE 29. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 37. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 39. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. CANADA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 45. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 47. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 49. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 51. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. CHINA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. INDIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 66. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. ITALY NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. QATAR NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. GLOBAL NARCOLEPSY TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 78. GLOBAL NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 79. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NARCOLEPSY TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL NARCOLEPSY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 38. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2019-2027 (USD MILLION)
TABLE 39. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY STATE, 2019-2027 (USD MILLION)
TABLE 41. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 51. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 58. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 60. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 61. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 62. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 64. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 65. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 66. CANADA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 68. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 69. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 70. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 72. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 73. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 77. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 84. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 86. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 87. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 88. CHINA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 90. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 91. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 92. INDIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 94. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 95. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 96. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 98. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 99. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 100. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 102. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 103. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 104. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 106. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 107. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 108. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 110. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 111. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 112. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 114. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 115. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 116. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 118. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 119. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 120. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 122. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 123. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 124. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 126. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 127. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 133. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 135. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 136. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 137. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 139. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 140. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 141. ITALY NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 142. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 143. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 144. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 145. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 147. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 148. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 149. QATAR NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 150. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 151. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 152. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 153. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 155. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 156. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 157. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 158. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 159. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 160. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 161. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 162. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 163. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 164. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 165. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 167. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 168. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 173. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 175. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2019-2027 (USD MILLION)
TABLE 176. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 177. GLOBAL NARCOLEPSY TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 178. GLOBAL NARCOLEPSY TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 179. GLOBAL NARCOLEPSY TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 180. GLOBAL NARCOLEPSY TREATMENT MARKET RANKING
TABLE 181. GLOBAL NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 182. GLOBAL NARCOLEPSY TREATMENT MARKET MERGER & ACQUISITION
TABLE 183. GLOBAL NARCOLEPSY TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 184. GLOBAL NARCOLEPSY TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 185. GLOBAL NARCOLEPSY TREATMENT MARKET INVESTMENT & FUNDING
TABLE 186. GLOBAL NARCOLEPSY TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 187. GLOBAL NARCOLEPSY TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Addrenex Pharmaceuticals, Inc.
  • Arena Pharmaceuticals, Inc.
  • Avadel Pharmaceuticals plc
  • Axsome Therapeutics
  • BIOPROJET
  • GlaxoSmithKline PLC
  • Graymark Healthcare Inc.
  • Harmony Biosciences LLC
  • Jazz Pharmaceuticals plc
  • Johnson & Johnson Services Inc.
  • Ligand Pharmaceuticals
  • Midas Pharma GmbH
  • Novartis AG
  • Pfizer Inc.
  • Shire Plc
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...